These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5292061)

  • 1. Serotonin and severe affective disorders.
    McLeod WR; McLeod MF
    Aust N Z J Psychiatry; 1971 Dec; 5(4):289-95. PubMed ID: 5292061
    [No Abstract]   [Full Text] [Related]  

  • 2. Deductive approaches to the catecholamine hypothesis of affective disorders.
    Wittenborn JR
    J Nerv Ment Dis; 1974 May; 158(5):320-4. PubMed ID: 4823932
    [No Abstract]   [Full Text] [Related]  

  • 3. Brain serotonin, affective illness, and antidepressant drugs: cerebrospinal fluid studies with probenecid.
    Goodwin FK; Post RM
    Adv Biochem Psychopharmacol; 1974; 11(0):341-55. PubMed ID: 4276863
    [No Abstract]   [Full Text] [Related]  

  • 4. Biogenic amine hypotheses of affective disorders.
    Garver DL; Davis JM
    Life Sci; 1979 Jan; 24(5):383-94. PubMed ID: 372718
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonin and affective disorders.
    Burns DD; Mendels J
    Curr Dev Psychopharmacol; 1979; 5():293-359. PubMed ID: 374000
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormalities of indoleamines in affective disorders.
    Coppen A; Prange AJ; Whybrow PC; Noguera R
    Arch Gen Psychiatry; 1972 May; 26(5):474-8. PubMed ID: 5019886
    [No Abstract]   [Full Text] [Related]  

  • 7. Biogenic amines and affective disorders.
    Schildkraut JJ
    Annu Rev Med; 1974; 25(0):333-48. PubMed ID: 4368455
    [No Abstract]   [Full Text] [Related]  

  • 8. Theoretical and therapeutic potential of indoleamine precursors. (1). Introduction.
    Wirz-Justice A
    Nihon Rinsho; 1976 Sep; 34(9):2741-5. PubMed ID: 1086914
    [No Abstract]   [Full Text] [Related]  

  • 9. Antidepressant treatments and alterations in central serotonin turnover in affective illness.
    Jimerson DC; Post RM; Goodwin FK
    Monogr Neural Sci; 1976; 3():15-22. PubMed ID: 790167
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.
    Goodwin FK; Post RM; Dunner DL; Gordon EK
    Am J Psychiatry; 1973 Jan; 130(1):73-9. PubMed ID: 4345466
    [No Abstract]   [Full Text] [Related]  

  • 11. Disturbances in tryptophan and serotonin metabolism in affective psychoses and schizophrenia.
    Puzyński S; Jakomow B
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):47-60. PubMed ID: 1107970
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-Hydroxytryptamine metabolism in affective illness: the effect of tryptophan administration.
    Ashcroft GW; Crawford TB; Cundall RL; Davidson DL; Dobson J; Dow RC; Eccleston D; Loose RW; Pullar IA
    Psychol Med; 1973 Aug; 3(3):326-32. PubMed ID: 4729192
    [No Abstract]   [Full Text] [Related]  

  • 13. Mood and neuronal functions: a modified amine hypothesis for the etiology of affective illness.
    Ashcroft GW; Glen AI
    Adv Biochem Psychopharmacol; 1974; 11(0):335-9. PubMed ID: 4845703
    [No Abstract]   [Full Text] [Related]  

  • 14. Biogenic amines and affective disorders. A critical analysis.
    Luchins D
    Int Pharmacopsychiatry; 1976; 11(3):135-49. PubMed ID: 136425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a biochemical classification of depression.
    van Praag HM
    Adv Biochem Psychopharmacol; 1974; 11(0):357-68. PubMed ID: 4845704
    [No Abstract]   [Full Text] [Related]  

  • 16. Substances related to 5-hydroxytryptamine in plasma and in lumbar and ventricular fluids of psychiatric patients.
    Curzon G; Kantamaneni BD; Van Boxel P; Gillman PK; Bartlett JR; Bridges PK
    Acta Psychiatr Scand Suppl; 1980; 280():3-20. PubMed ID: 6157303
    [No Abstract]   [Full Text] [Related]  

  • 17. Sources of contribution to the understanding of the etiology of mood disorders.
    Lipton MA; Prange AJ; Wilson IC
    Proc Annu Meet Am Psychopathol Assoc; 1972; 60():117-31. PubMed ID: 4621831
    [No Abstract]   [Full Text] [Related]  

  • 18. Labelled 5-hydroxytryptamine and 5-hydroxyindoleacetic acid formed in vivo from 3H-tryptophan in rat brain effect of probenecid.
    Schubert J
    Acta Physiol Scand; 1974 Feb; 90(2):401-8. PubMed ID: 4823013
    [No Abstract]   [Full Text] [Related]  

  • 19. Central serotonin deficiency--a factor which increases depression vulnerability?
    van Praag HM; de Haan S
    Acta Psychiatr Scand Suppl; 1980; 280():89-96. PubMed ID: 6157306
    [No Abstract]   [Full Text] [Related]  

  • 20. Indoleamines and affective disorders.
    Coppen A
    J Psychiatr Res; 1972 Sep; 9(3):163-71. PubMed ID: 5083172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.